Bugworks Research, a Bengaluru and Delaware-based bio-pharma startup, has raised a Series A round of $9 million (about Rs.62.2 cr.) led by the University of Tokyo Edge Capital (UTEC). The company plans to use the funds to deepen its clinical trials.
Loading - Please wait
Date posted: Tuesday 14 August 2018
Bugworks Research, a Bengaluru and Delaware-based bio-pharma startup, has raised a Series A round of $9 million (about Rs.62.2 cr.) led by the University of Tokyo Edge Capital (UTEC). The company plans to use the funds to deepen its clinical trials.